The mycoplasma testing market grew from $0.94 billion in 2023 to $1.08 billion in 2024, showcasing a CAGR of 14.0%. This growth was driven by contamination incidents, increased awareness, and the expansion of the biotechnology sector. The market is forecasted to reach $1.71 billion by 2028, with a slightly reduced CAGR of 12.2%. Future growth drivers include quality assurance demands, biopharmaceutical industry growth, and cell-based therapies. Key trends include regulatory compliance, innovation in point-of-care testing, and increased diagnostics awareness.
Major Driver In The Mycoplasma Testing Market
The mycoplasma testing market anticipates growth propelled by the increasing prevalence of mycoplasma pneumonia, a respiratory infection caused by Mycoplasma pneumoniae bacteria. Mycoplasma testing plays a pivotal role in diagnosing this infection by detecting the presence of Mycoplasma pneumoniae bacteria in respiratory specimens, enabling timely and accurate medical interventions. For instance, the Centers for Disease Control and Prevention estimate approximately 2 million cases of Mycoplasma pneumoniae infections annually in the United States alone. Consequently, the rising prevalence of mycoplasma pneumonia underscores the imperative for mycoplasma testing, thus driving the growth of the mycoplasma testing market.
Request A Free Sample Of The Global Mycoplasma Testing Market Report
Mycoplasma Testing Market Competitive Landscape
Abbott Laboratories, Merck KGaA, Thermo Fisher Scientific Inc., Boston Scientific Corporation, Olympus Corporation, Agilent Technologies Inc., Lonza Group AG, Roche Diagnostics International AG, Smith & Nephew plc, Charles River Laboratories International Inc., CONMED Corporation, Nelson Laboratories Fairfield Inc., AngioDynamics Inc., Creative Bioarray, Biological Industries Israel Beit Haemek Ltd., Biotools B & M Labs S.A, PromoCell GmbH, American Type Culture Collection, Bionique Testing Laboratories Inc., InvivoGen, Clongen Laboratories LLC, Norgen Biotek Corporation, Gen Bio Sciences (P) Ltd., GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, ScienCell Research Laboratories Inc., AtriCure Inc., Advanced Cardiac Therapeutics Inc., ARTWORKSIT
Key Mycoplasma Testing Market Trend
Major players operating in the market are undertaking various strategic investments such as the launch of innovative products, research and development advancements, and technological innovations, which are gaining significant popularity in the mycoplasma testing market. Companies are introducing new innovative products to meet the requirements of end-users and expand the consumer base to survive in the competitive business environment. For instance, in October 2022, SwiftDx, a UK-based biotechnology company, launched a new detection test for mycoplasma contamination using a PCR-based method. The SwiftDx Mycoplasma Detection Kit is a lateral flow test that offers a quick and accurate way to detect mycoplasma. The test uses a small sample directly from the cell culture media supernatant without interrupting cell growth. The results are displayed in a simple and easy-to-read format. The test is highly sensitive and specific with a detection limit of less than 10 cfu/mL after day 3 of culture.
Get The Full Global Mycoplasma Testing Market Report
Mycoplasma Testing Market Segmentation
The mycoplasma testing market covered in this report is segmented –
1) By Product: Instruments, Assay, Kits, and Reagents
2) By Technology: PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies
3) By Application: Cell line Testing, Virus Testing, End- of- Production Cell Testing
4) By End User: Pharmaceutical & Biotechnology Companies, Cell Banks & Laboratories, Contract Research Organizations, Academic Research Institutes
By Geography:The regions covered in the mycoplasma testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the mycoplasma testing market in 2023.
The Mycoplasma Testing Global Market Report 2024 furnishes information about the global mycoplasma testing market, encompassing details like market size, projections for growth, segmentation across various sectors and regions, and an overview of competitors, including their revenues, profiles, and market shares. Furthermore, the report pinpoints potential opportunities and strategic directions derived from market trends and the strategies adopted by key competitors. The report also offers an assessment of how the COVID-19 pandemic, the Russia-Ukraine conflict, and increasing inflation have affected both global and regional markets, furnishing valuable strategic insights for businesses.
